Amneal Pharmaceuticals Inc. (AMRX)
NASDAQ
Closed
Aug 24, 2026
Day's Range
17.6152 wk Range
9.20Overview - AMRX - Amneal Pharmaceuticals Inc.
Key Statistics
Valuation
Enterprise Value
8.46B
P/E (Trailing)
‪37.60‬
P/E (Forward)
‪15.03‬
PEG Ratio
‪0.23‬
Price / Sales (TTM)
‪2.01‬
Price / Book
‪175.24‬
EV / EBITDA
‪12.27‬
Profitability
Gross Margin
‪42.01%‬
Profit Margin
‪5.04%‬
Operating Margin
‪18.33%‬
Return on Assets
‪8.59%‬
Return on Equity
‪613.01%‬
Ownership
Shares Outstanding
319.33M
Float
186.05M
Short % of Shares Outstanding
‪3.85%‬
Held by Insiders
‪52.16%‬
Held by Institutions
‪48.41%‬
Price stats
Beta
‪1.25‬
50-Day Avg
‪17.46‬
200-Day Avg
‪14.03‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
4 analysts
Average price target
‪$ 20.75‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AMRX - Amneal Pharmaceuticals Inc.
Peers - AMRX - Amneal Pharmaceuticals Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NASDAQ.
- AMRXNASDAQAmneal Pharmaceuticals Inc.6.23BMarket Cap+48.19%52-week change37.60P/E (Trailing)‪5.04%‬Profit Margin
- NBIXNASDAQNeurocrine Biosciences Inc.15.50BMarket Cap+12.18%52-week change22.34P/E (Trailing)‪20.91%‬Profit Margin
- ALALKSNASDAQAlkermes plc8.10BMarket Cap+40.00%52-week change127.37P/E (Trailing)‪3.96%‬Profit Margin
- LNTHNASDAQLantheus Holdings, Inc.6.52BMarket Cap+43.82%52-week change23.92P/E (Trailing)‪17.69%‬Profit Margin
- KNKNSANASDAQKiniksa Pharmaceuticals International, plc6.16BMarket Cap+58.19%52-week change79.83P/E (Trailing)‪9.59%‬Profit Margin
- ALMNASDAQAlmonty Industries Inc.5.33BMarket Cap+76.82%52-week change84.14P/E (Trailing)‪125.23%‬Profit Margin
- AMLXNASDAQAmylyx Pharmaceuticals, Inc. Common Stock4.41BMarket Cap+76.55%52-week change2.54P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - AMRX - Amneal Pharmaceuticals Inc.
About
Amneal Pharmaceuticals Inc. is a global biopharmaceutical company that develops, manufactures, and distributes a diverse portfolio of essential medicines across three reportable segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers a broad range of generic pharmaceuticals in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
